healthbook Webinars
Upcoming
On Demand
healthbook Congress Newsrooms
healthbook TIMES
Edition 1 | 2022
- Open Access Review Articles
- CAR-T Cell Therapy Highlights
- AL Amyloidosis and Multiple Myeloma Highlights
- Carfilzomib as Second-Line Therapy
- Congress Snapshots and Highlights
TIMES Edition 1–2 | 2022
- Perspektiven für Fachärzte, Internisten & Hausärzte
- Expertenmeinungen
- Open Access Articles